AIMET

What AIMET does

AIMET (AI for Mental Health), legally the Center of Excellence in Digital Innovation and Artificial Intelligence for Psychiatric Medicine, is a Thailand-based research and innovation center founded in 2021 and housed at Chulalongkorn University's Faculty of Engineering in Bangkok. The organization develops AI-powered digital health tools aimed at expanding access to mental and cognitive health services for the Thai population, addressing a documented shortage of psychiatric professionals relative to population size. Its core products include DMIND, a multi-modal AI depression screening app combining facial expression, voice, and text analysis; Emmind, a CBT-based emotional regulation web application delivered via LINE; C2Fit, a brain health assessment tool; Digital Thai MoCA, a cognitive impairment screening tool; a mental health chatbot; and i-ExC Game, a cognitive training program for older adults.

AIMET's platform is built on a multi-modal AI stack spanning natural language processing, computer vision, and speech/audio analysis, developed in collaboration with Chulalongkorn University's Department of Computer Engineering and clinically validated with the university's Faculty of Medicine and King Chulalongkorn Memorial Hospital. The organization operates a multi-stakeholder ecosystem that includes government partners (National Economic and Social Development Board, Department of Mental Health, NHSO) and clinical infrastructure, with DMIND directly integrated into the national Mental Health Hotline 1323 for crisis escalation. The four-year mission targets 15 innovations scaling to at least 100,000 users each, with a satisfaction score of 4 out of 5.

AIMET does not operate on a commercial revenue model. All products are provided free to end users, and the organization is funded through government and institutional partnerships as a non-profit research center rather than venture capital. Customer segments are the general Thai population for self-service mental health screening and emotional regulation, alongside mental health professionals and healthcare providers using AIMET tools as clinical screening support. With 31 employees and an active hiring program across AI, product, and marketing roles, AIMET is positioned as a public-benefit R&D platform rather than a commercial SaaS business.

Name

AIMET

Legal name

ศูนย์ความเป็นเลิศด้านนวัตกรรมดิจิทัลและปัญญาประดิษฐ์เพื่อการแพทย์ด้านจิตเวช (AIMET - Center of Excellence in Digital Innovation and Artificial Intelligence for Psychiatric Medicine)

Website

https://aimet.tech

Company type

Private

Founded year

2021

Operating status

Operating

Headcount range

11–50 employees

Short description

AIMET is a Thai non-profit research center at Chulalongkorn University building AI-powered mental and cognitive health screening tools — including DMIND (depression screening) and Emmind (CBT-based emotional regulation) — for the Thai population, funded by government and institutional partnerships rather than commercial revenue.

Ownership category

akta.pro rank

Product category

Digital Mental Health Software

NAICS

Software Publishers (5132), Research and Development in the Social Sciences and Humanities (54172)

SIC

Services-Prepackaged Software (7372), Services-Social Services (8300)

akta.pro industry

PRIMARYHLACANAI

Behavioral Health & Neurocognitive Therapeutics (Digital)

Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)

SECONDARYHLALAEAI

Crisis Support, Suicide Prevention & Acute Behavioral Triage Platforms

Healthcare & Life Sciences/Telehealth Platforms/Behavioral & Mental Health Teletherapy Platforms

SECONDARYEDAFAKAG

Executive Functioning & Behavioral Support Tools (ADHD, SEL/Behavior Tracking, Routines)

Education/Education Technology (EdTech) & Digital Learning/Accessibility, Assistive Technology & Special Needs EdTech

Keywords

• Mental health screening
• Depression detection AI
• Cognitive health assessment
• CBT emotional regulation
• Digital psychiatric medicine

Headquarters

HQ city

Bangkok

HQ country

Thailand

HQ region

Asia

Offices2 records

Markets served

GTM type

B2C

Offering type

Software

Cost components

Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure

Revenue model

1. Non-profit Research Center: AIMET operates as a research and innovation center funded through government and institutional partnerships. The organization focuses on developing public benefit mental health solutions rather than commercial revenue generation.

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels4 records

Core offering

AIMET builds and distributes AI-powered mental and cognitive health software applications to the Thai population free of charge. Its products include DMIND for multi-modal depression screening, Emmind for CBT-based emotional regulation, C2Fit for brain health assessment, Digital Thai MoCA for cognitive impairment screening, a mental health chatbot, and the i-ExC cognitive training game. All solutions are developed at Chulalongkorn University and made available via web and LINE platforms.

Product overview

AIMET operates as a multi-product mental and cognitive health innovation center, offering a portfolio of AI-powered digital health solutions. The core products include DMIND (AI depression screening app), Emmind (CBT-based emotional regulation web app), C2Fit (AI brain health assessment), Digital Thai MoCA (cognitive impairment screening), Chatbot (mental health conversational AI), and i-ExC Game (cognitive training games). DMIND leverages multi-modal AI analysis (face, voice, text) for depression risk assessment, while Emmind provides web-based CBT therapy exercises. These products are developed in collaboration with Chulalongkorn University and supported by Thai government health agencies.

Differentiator

Problem solved

Functional benefit

Brands

• DMIND: Depression screening application with AI that listens to users' stories and evaluates depression risk through facial expression, voice, and text analysis.
• Emmind
• C2Fit
• Digital Thai MoCA
• Mental Supporter Chatbot

Products and services

• DMIND

Named customers2 records

Segments2 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability6 records

Feature3 records

Partnerships

Seven partnerships are on record, tiered core and minor.

• National Economic and Social Development Board (สภาพัฒน์)coreStrategic or Co-development PartnerGovernment partner supporting AIMET's mission to develop digital innovations for mental health. Listed as partner and supporter on AIMET website.
• Chulalongkorn University - Faculty of EngineeringcoreStrategic or Co-development PartnerCore academic partner providing technical expertise in AI and software development. Home to Department of Computer Engineering where AIMET is located.
• Chulalongkorn University - Faculty of MedicinecoreStrategic or Co-development PartnerClinical partner providing psychiatric and medical expertise for developing validated mental health AI solutions.
• King Chulalongkorn Memorial HospitalcoreStrategic or Co-development PartnerClinical testing and validation partner for mental health AI applications.
• Department of Mental Health (กรมสุขภาพจิต)coreStrategic or Co-development PartnerGovernment health agency partner providing mental health hotline (1323) integration with DMIND and ongoing project support for EMMIND. Collaborates on government-level mental health initiatives.
• Mental Health Hotline 1323coreStrategic or Co-development PartnerIntegration partner connecting DMIND screening results to mental health crisis response services.
• National Health Security Office (NHSO/สปสช.)minorStrategic or Co-development PartnerPartner supporting healthcare coverage and access to mental health services.

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• BetterHelp: BetterHelp is a large online therapy platform addressing the same pain point — limited access to mental health services — that AIMET targets. Both serve as scalable alternatives to traditional in-person psychiatric care.
• Calm: Calm is a global consumer mental health and mindfulness app. While less clinical than AIMET, it competes for the same consumer mindshare in mental wellness and self-guided emotional regulation.
• Lyra Health: Lyra Health provides mental health support through employers, including AI-driven care navigation and a global provider network. It is comparable to AIMET in its screening-plus-treatment pathway, though at enterprise scale.
• Spring Health: Spring Health is a global mental health benefits platform used by employers and health plans, combining AI-driven assessment with therapist matching. Its AI screening — including depression and anxiety — closely mirrors DMIND's screening-plus-navigation model.
• Headspace Health: Headspace Health (Ginger + Headspace) is a leading consumer mental health platform offering self-guided content, coaching, and therapy. It overlaps with AIMET's broader mental and emotional wellness positioning and Thai-population screening and intervention offerings.

Direct peers

• Wysa: Wysa is an AI mental health chatbot combining CBT, DBT, and conversational support. It directly parallels AIMET's Emmind and Mental Supporter Chatbot, targeting accessibility and early intervention outside clinical settings.
• Woebot Health: Woebot Health builds an AI-driven CBT-based mental health chatbot, which is the same therapeutic modality and consumer channel as AIMET's Emmind product. Both deploy AI to deliver structured mental health interventions at scale.

Regional players

• Alodokter: Alodokter is a leading Southeast Asian digital health platform operating in Indonesia. It is comparable to AIMET as a regional digital health player expanding mental health and AI-driven triage features within emerging Asian markets.
• Doctor Anywhere: Doctor Anywhere is a Southeast Asia–focused digital health platform offering telehealth, mental health, and chronic care. It is comparable to AIMET for the regional digital health opportunity in Thailand-adjacent markets.

Emerging players

• Big Health (Sleepio): Big Health develops digital therapeutics (e.g., Sleepio for insomnia) that are clinically validated and deployed through healthcare systems. It is comparable to AIMET's digital therapeutic positioning around cognitive and emotional health.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/aimet.tech
• LinkedInlinkedin.com/company/aimet-tech

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about AIMET